Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Strategies for Assessing and Addressing Confounding

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

Confounding in Epidemiological Studies

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Products That Pose Health Risks - Can Litigation Protect Us When Government Fails?

The New England journal of medicine·2026

Same author

Patterns of antithrombotic treatment after left atrial appendage occlusion.

Heart rhythm·2026

Same author

Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps.

JAMA internal medicine·2026

Same author

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

JAMA network open·2026

Same author

List Price Reductions Among Brand-Name ICS-LABA Inhalers In 2024 Were Associated With Increased Generic Uptake.

Health affairs (Project Hope)·2026

Same author

Risk of neutropenia-related hospitalisation among clozapine initiators.

BMJ mental health·2026

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.

Til Stürmer¹, Robert J Glynn, Kenneth J Rothman

¹Divisions of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. til.sturmer@post.harvard.edu

|October 25, 2007

Summary

Validation studies enhance pharmacoepidemiology by addressing unmeasured confounding in drug effect assessments. Propensity score calibration (PSC) offers a method to adjust for unmeasured confounders using external validation data, improving real-world drug safety evaluations.

Related Experiment Videos

Last Updated: Jul 11, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

Pharmacoepidemiology
Biostatistics
Health Services Research

Background:

Nonexperimental drug studies in large databases face challenges with unmeasured confounding.
Timely assessment of real-world drug use is crucial but limited by data availability.
Uncontrolled variables in automated databases can bias drug effect estimations.

Purpose of the Study:

To demonstrate how validation studies can mitigate unmeasured confounding in pharmacoepidemiologic research.
To explore methods for incorporating external data to adjust for unmeasured confounders.
To improve the reliability of real-world drug effect estimates.

Main Methods:

Reviewed validation study designs for adjusting unmeasured confounding.
Utilized an external validation study with a representative sample of Medicare beneficiaries.
Applied propensity score calibration (PSC) to estimate drug effects.

Main Results:

Validation studies are classified as internal or external.
Propensity score calibration (PSC) provided a plausible estimate for NSAID-mortality association in the elderly.
External validation data, even without disease outcome, can adjust for unmeasured confounding under specific assumptions.

Conclusions:

Validation studies enable adjustment for confounders absent in main studies.
PSC offers a method for adjusting unmeasured confounding using validation data lacking disease outcome information.
Encourages the integration of validation data in pharmacoepidemiology to enhance study validity.